Aroa Biosurgery Ltd has released a press release.
Aroa Biosurgery H1 FY26 Results
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Aroa Biosurgery
- Appendix 4D and Half Year Report
- September 2025 Quarterly Report and Appendix 4C
- First clinical evidence published on AROA's ENIVO™ system for surgical dead space management.
- June 2025 Quarterly Report and Appendix 4C
- FY25 Full Year Results Presentation
Later from Aroa Biosurgery
- Study demonstrates effectiveness and economic value of Myriad™ in trauma and acute care surgery.
- AROA Business Update
- AROA Business Update Presentation
- Symphony Randomised Control Trial Complete
- ARX FY26 Preliminary Results
Follow Aroa Biosurgery into a list and get an email when it puts out news.
Follow Aroa Biosurgery